Trial intelligence / Profile preview

Alfentanil combined with desflurane for intraoperative arousal in peripheral functional tumor surgery

ChiCTR2100044012Phase 4Recruiting

Sponsor
Fushun Mining Bureau General Hospital
Start
Mar 2021
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4 trial of desflurane, sevoflurane, remifentanil and alfentanil in peripheral nerve sheath neoplasm and peripheral functional tumor (2 arms), sponsored by Fushun Mining Bureau General Hospital. Primary endpoints: Blood pressure, Heart rate and 2 more. Started Mar 2021; status: recruiting.

02

Drugs

desfluranesevofluraneremifentanilalfentanil
03

Conditions

peripheral nerve sheath neoplasmperipheral functional tumor

Beyond the preview

Go deeper on ChiCTR2100044012.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2100044012.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call